Publications

Hunt BC, Brix V, Deka N, Learman BS, Brauer AL, Shipman BM, De Nisco NJ, Armbruster CE. Chondroitin sulfate degradation bolsters Proteus mirabilis growth and colonization of the catheterized urinary tract. Infect Immun. 2026 Sep 1:e0022326. doi: 10.1128/iai.00223-26. Epub ahead of print. PMID: 42684860.

Koonjbearry, NS, et. al. Complete genome sequences of Streptococcus agalactiae urine isolates collected from postmenopausal women. Microbiol Resour Announce, August 2026

Zimmern PE, et. al. Design and methodology of a randomized clinical trial of prolonged daily antibiotic suppression with and without fulguration for uncomplicated recurrent urinary tract infections in women. medRxiv, May 2026

Shipman BM, et. al. Strain level variation in Proteus mirabilis chondroitin sulfate degradation kinetics and regulation by urea. bioRxiv, March 2026

Gadhvi JG, et. al. Bladder wall-embedded bacteria associated with increased risk of recurrence after electrofulguration in women with antibiotic-recalcitrant urinary tract infection. JU Open Plus, July 2025

Neugent ML, et. al. Urinary biochemical ecology reveals microbiome-metabolite interactions and metabolic markers of recurrent urinary tract infection. NPJ Biofilms Microbiomes, November 2025

Lutz KC, et. al. MiCoDe: a web tool for performing microbiome community detection using a Bayesian weighted stochastic block model. Bioinformatics, July 2025

Koirala S, et. al. Fluorescent molecular probe for in vivo and in vitro targeting and imaging of an intracellular bacterial infection. Chem Sci, March 2025

Lutz KC, et. al. A Generalized Bayesian Stochastic Block Model for Microbiome Community Detection. Stat Med., February 2025

Saenz CN, et. al. The Human Urinary Microbiome and Its Potential Role in Urinary Tract Infections. Eur Urol Focus, December 2024

Cornelius SA, Basu U, Zimmern PE, De Nisco NJ. Overcoming challenges in the management of recurrent urinary tract infections. Expert Rev Anti Infect Ther. 2024 Dec;22(12):1157-1169. doi: 10.1080/14787210.2024.2412628. Epub 2024 Oct 10. PMID: 39387179; PMCID: PMC11634670.

Dalvi H, De Nisco NJ. The evolving world of the urinary microbiome. Curr Opin Urol. 2024 Nov 1;34(6):422-427. doi: 10.1097/MOU.0000000000001222. Epub 2024 Sep 2. PMID: 39224916

Johnson AO, Shipman BM, Hunt BC, Learman BS, Brauer AL, Zhou SP, Hageman Blair R, De Nisco NJ, Armbruster CE. Function and contribution of two putative Enterococcus faecalis glycosaminoglycan degrading enzymes to bacteremia and catheter-associated urinary tract infection. Infect Immun. 2024 Jul 11;92(7):e0019924. doi: 10.1128/iai.00199-24. Epub 2024 Jun 6. PMID: 38842305; PMCID: PMC11238560.

Zimmern PE, De Nisco NJ, Prokesch BC. Electrofulguration for Women With Uncomplicated Recurrent Urinary Tract Infections and Chronic Cystitis: Time for Trials! J Urol. 2024 Jul;212(1):220-222. doi: 10.1097/JU.0000000000003943. Epub 2024 May 6. PMID: 38708877.

Ebrahimzadeh T, Basu U, Lutz KC, Gadhvi J, Komarovsky JV, Li Q, Zimmern PE, De Nisco NJ. Inflammatory markers for improved recurrent UTI diagnosis in postmenopausal women. Life Sci Alliance. 2024 Feb 8;7(4):e202302323. doi: 10.26508/lsa.202302323. PMID: 38331474; PMCID: PMC10853434.

Sawant NV, Chang SS, Pandit KA, Khekare P, Warner WR, Zimmern PE, De Nisco NJ. VesiX cetylpyridinium chloride is rapidly bactericidal and reduces uropathogenic Escherichia coli bladder epithelial cell invasion in vitro. Microbiol Spectr. 2024 Mar 5;12(3):e0271223. doi: 10.1128/spectrum.02712-23. Epub 2024 Jan 19. PMID: 38240572; PMCID: PMC10913388.

Nguyen VH, Sharon BM, Shipman BM, Zimmern PE, De Nisco NJ. Complete genomes of Limosilactobacillus portuensis and Limosilactobacillus vaginalis isolated from the urine of postmenopausal women. Microbiol Resour Announc. 2024 Jan 17;13(1):e0088323. doi: 10.1128/MRA.00883-23. Epub 2023 Nov 29. PMID: 38018964; PMCID: PMC10793329.